How to Get GLP-1 Patients as a Prescriber

You’ve spent years mastering psychiatric care — medication management, behavioral interventions, helping patients navigate complex mental health challenges. Now there’s a massive opportunity sitting in your exam room that you might not have fully considered: weight management with GLP-1 medications.

Before you dismiss this as ‘not my specialty,’ consider the reality: Nearly half of psychiatrists are already prescribing or recommending GLP-1 drugs like Ozempic and Wegovy. Your patients are asking about them. Many are struggling with medication-induced weight gain from antipsychotics or mood stabilizers. And the demand is absolutely exploding — GLP-1 usage for weight loss increased roughly 600% over six years, with an estimated 20 million Americans actively taking these medications by late 2025.

Here’s what makes this opportunity different from traditional practice expansion: you already have the clinical foundation, the patient relationships, and the telehealth infrastructure. What you need is a clear roadmap for scaling this service without drowning in administrative work or sacrificing your quality of life.

Let me show you how psychiatrists are building sustainable, profitable GLP-1 practices — and doing it in a way that actually improves their work-life balance.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

You’re Already Managing Chronic Conditions with Behavioral Components

Weight management isn’t that different from what you do every day. Both require:

• Long-term medication management with dose titration
• Monitoring for side effects and mental health changes
• Behavioral counseling and motivation
• Regular follow-ups to sustain progress
• Managing patient expectations about timelines and outcomes

The difference? GLP-1 patients typically see dramatic, tangible results within weeks. That’s rewarding for both you and your patients — a nice contrast to the slower progress often seen in psychiatric treatment.

Your Current Patients Are Prime Candidates

Look at your caseload right now. How many patients complain about weight gain from their psychiatric medications? How many have metabolic syndrome, prediabetes, or obesity alongside their mental health diagnoses?

These aren’t separate problems — they’re interconnected. Addressing weight can improve mood, energy, and self-esteem. And you’re already in a trusted therapeutic relationship where patients feel comfortable discussing sensitive health issues.

One psychiatrist described it this way: offering GLP-1 treatment to patients struggling with antipsychotic-induced weight gain transforms the conversation from ‘necessary evil’ to ‘we’re treating the whole person.’ That’s powerful for retention and satisfaction.

You Bring Mental Health Expertise Others Don’t Have

Primary care doctors and weight-loss clinics can prescribe GLP-1s, but they often miss the psychological piece. Weight loss is never just about the medication — it’s about addressing emotional eating, body image issues, anxiety around food, depression that saps motivation for lifestyle changes.

You’re trained to spot these patterns. You can manage the rare mood changes or anxiety that some patients experience on GLP-1s. You understand the mental health implications of rapid weight loss. This holistic approach is what patients actually need for lasting success, and it’s a massive differentiator in a crowded market.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Business Case: Patient Demand vs. Provider Supply

Let’s talk numbers, because this isn’t just about clinical fit — it’s about practice viability.

The demand side is staggering:

• Roughly 75% of Americans are overweight or obese
• By 2024, about 2% of Americans were using GLP-1s for weight loss — by late 2025, that jumped to 6% (about 20 million people)
• Tens of thousands of new patients start these medications every week
• Many patients can’t access specialized obesity clinics due to waitlists, geography, or cost

The supply side is limited:

• There are far fewer obesity medicine specialists than needed to meet demand
• Most primary care doctors lack time or training to provide ongoing weight management
• Telehealth weight-loss companies are growing rapidly, but many lack the mental health integration patients need

What this means for you: There’s a massive gap between patient demand and qualified providers. You can fill that gap, especially via telehealth, which eliminates geographic barriers and lets you serve patients across your entire licensed state(s).

The Revenue Model Reality

Let’s be honest about economics. Adding GLP-1 care can significantly boost practice revenue, but you need to understand the financial structure.

Cash-pay is the predominant model for good reason: As of 2024, only 13 state Medicaid programs covered GLP-1s for weight loss, and many private insurers exclude obesity treatment. Patients are used to paying out-of-pocket for these medications (brand-name drugs can cost $1,300+ monthly without coverage, compounded versions $200-400).

Typical cash-pay structure:

• Initial consultation: $150-300 (comprehensive evaluation, labs review, treatment plan)
• Monthly follow-ups: $99-150 during active dose titration
• Maintenance visits: $99-150 every 2-3 months once stable
• Medication: Patients pay separately (either through insurance if they have coverage, cash-pay at pharmacy, or via compounded prescriptions)

Some practices use subscription models ($199-299/month all-inclusive) that bundle consultations, support, and medication access. Others charge per visit and keep medication costs separate.

Insurance billing is possible but trickier: You can bill standard E/M codes for obesity counseling or use Medicare’s G0447 behavioral counseling code. But expect prior authorizations, potential denials, and lower reimbursement. Many psychiatrists prefer cash-pay for simplicity and direct revenue.

The key question: Can you scale patient volume profitably without burning out? That’s what the rest of this guide addresses.

Building Your GLP-1 Service: The Practical Roadmap

Step 1: Get Clear on Scope and Compliance

Licensing Requirements:You must be licensed in every state where your patients are located. Period. No exceptions, even for telehealth.

• Psychiatrists (MD/DO): You have full prescriptive authority in all states. No scope of practice issues.
• PMHNPs: Your ability to prescribe GLP-1s independently depends on your state:
• Independent practice states: California (if you’ve completed the AB 890 transition to 104 NP status, starting 2026), New York (after 3,600 practice hours), Illinois (after 4,000 hours + education for FPA status)
• Collaborative practice required: Texas, Pennsylvania, Florida (except primary care NPs with specific experience)

If you’re an NP in a collaborative state, you’ll need a supervising physician agreement. Many telehealth platforms handle this for you by pairing you with a supervising MD.

Federal and State Prescribing Rules:GLP-1 medications (semaglutide, tirzepatide, liraglutide) are not controlled substances, which means:

• No DEA restrictions
• No Ryan Haight Act in-person exam requirement
• You can prescribe via telehealth in any state where you’re licensed

State-specific telehealth requirements vary but generally include:

• Establishing a valid patient-provider relationship (can be via synchronous video)
• Meeting the same standard of care as in-person
• Proper documentation
• Patient consent for telemedicine (required explicitly in California, good practice everywhere)

Some states make it easier:

• Florida offers out-of-state telehealth provider registration for physicians, avoiding full licensure
• Texas, Illinois, Pennsylvania are Interstate Medical Licensure Compact (IMLC) members, streamlining multi-state licensing for MDs/DOs
• California and New York are NOT in the IMLC — you need full state licenses

Off-label prescribing note: If you’re using Ozempic (approved for diabetes) for obesity, that’s off-label but perfectly legal. Document medical necessity (BMI ≥30 or ≥27 with comorbidities), obtain informed consent, and educate patients about the use. Wegovy is FDA-approved specifically for obesity, so no off-label issue there.

Step 2: Design Your Clinical Workflow for Efficiency

The biggest mistake providers make? Treating every GLP-1 patient like a complex psychiatric case requiring hour-long sessions. These can be streamlined, efficient visits once you have systems in place.

Initial Evaluation (30-45 minutes):Create a standardized intake process:

• Pre-visit: Digital intake form captures weight history, current medications, medical conditions, diet/exercise habits, mental health screening, contraindications checklist
• Labs ordered before first visit: A1c, fasting glucose, TSH, comprehensive metabolic panel (some providers also check lipids, CBC)
• Video consultation covers:
• Review of medical and psychiatric history
• Assessment of contraindications (history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis)
• Current medications and potential interactions
• Mental health screening (depression, anxiety, eating disorders)
• Goal-setting (realistic weight loss targets, timeline expectations)
• Education on medication (how it works, injection technique, side effects)
• Lifestyle counseling basics (nutrition, exercise, sleep, stress)
• Informed consent and treatment agreement

Use template documentation to speed up charting. After doing 10-20 initial consults, you’ll recognize the patterns and can build smart phrases or templates that capture required elements while allowing for individual patient details.

Follow-up Visits (15-20 minutes):These should be monthly during dose titration, then every 2-3 months once stable.

Standard follow-up template:

• Weight and BMI (collected via patient portal or at start of visit)
• Side effects check (nausea, constipation, fatigue, mood changes)
• Adherence to medication and lifestyle plan
• Progress toward goals
• Medication adjustment if needed (dose titration per standard protocols)
• Brief counseling reinforcement
• Next steps and follow-up timing

The key to scale: Brief, focused follow-ups. You’re not doing 50-minute psychotherapy. You’re managing a chronic medication, monitoring progress, and providing support. Most stable patients need 15 minutes every 8-12 weeks once they’re on a maintenance dose.

Step 3: Leverage Technology and Delegation

Choose the right platform:If you’re building this independently, invest in a telehealth EHR that integrates:

• Video visits with good quality/reliability
• E-prescribing (including to compounding pharmacies if needed)
• Patient portal for messaging, intake forms, and data collection
• Appointment scheduling with automated reminders
• Template documentation and smart phrases

Automate repetitive tasks:

• Appointment reminders via text/email reduce no-shows
• Pre-visit questionnaires collect weight, side effects, adherence data before the visit
• Educational content can be sent automatically (e.g., ‘Starting GLP-1s: What to Expect’ goes out with first prescription)
• FAQ chatbot or knowledge base handles common questions (‘Is nausea normal?’ ‘How do I store my pen?’) without requiring your time

Remote monitoring tools:Some practices issue connected scales that automatically upload patient weights to the EHR. Others use simple smartphone apps where patients log weight weekly. Either way, you get trend data at a glance instead of asking ‘So, what’s your weight today?’

Delegate non-clinical work:If you have medical assistants, RNs, or health coaches on staff (or can hire them), delegate:

• Collecting vitals and patient-reported data before visits
• Initial insurance verification or cash payment processing
• Scheduling follow-ups and managing the calendar
• Responding to routine portal messages (with your review/approval)
• Leading group education sessions or support groups

For example: An RN or health coach can run a monthly 30-minute group Zoom call on ‘Managing Side Effects’ or ‘Nutrition Tips on GLP-1s.’ This provides value to patients, builds community, and takes repetitive counseling off your plate. You can pop in for 5 minutes to answer questions, but you’re not doing the same dietary education 50 times one-on-one.

Step 4: Structure Your Services for Sustainability

Start small and scale gradually:Don’t try to go from zero to 100 GLP-1 patients in a month. That’s how burnout happens.

Recommended approach:

• Month 1-2: Offer GLP-1 care to existing psychiatric patients who meet criteria. This is the easiest path — you already have the relationship, they trust you, and there’s no marketing needed. Aim for 5-10 patients to refine your workflow.
• Month 3-4: Start accepting new GLP-1-only patients, but cap it (e.g., 2-3 new weight-loss consults per week). Adjust your systems based on what you learned.
• Month 5+: Gradually increase volume as you build efficient processes. Consider dedicated ‘GLP-1 clinic hours’ (e.g., Friday afternoons) to batch similar appointments.

Protect your time with boundaries:

• Set specific hours for patient communication (e.g., messages answered 9am-5pm weekdays)
• Use scheduling rules to prevent overbooking (e.g., max 4 initial consults per day, since they’re more intensive)
• Build in admin time blocks for charting, prescription renewals, prior auths
• Take regular time off — the beauty of telehealth is you can work from anywhere, but that doesn’t mean work all the time

Create retention and compliance systems:The best practices for long-term success:

• Monthly check-ins during active weight loss keep patients accountable and let you catch issues early
• Patient education materials (handouts, videos) reduce repetitive questions
• Support group or community forum where patients encourage each other
• Milestone celebrations (reaching 10% weight loss, etc.) boost motivation
• Clear expectations upfront about timelines, realistic weight loss, lifestyle requirements, costs

Retention matters because a patient who stays with you for 12+ months generates significantly more revenue than one who drops out after 2 months. Plus, better clinical outcomes mean better word-of-mouth referrals.

How to Get Patients: Marketing That Works

Here’s the reality of patient acquisition: You’re not going to acquire qualified GLP-1 patients for $30-50 each through DIY marketing. That’s fantasy. Let’s talk real numbers and real strategies.

The True Cost of DIY Patient Acquisition

If you decide to market independently (SEO, Google Ads, directory listings), understand what you’re actually committing to:

SEO (search engine optimization):

• Timeline: 6-12 months before meaningful patient flow
• Costs: $2,000-5,000+/month for quality content, technical optimization, and link building (either agency fees or your time if doing it yourself)
• Reality: You’re competing with multi-million dollar telehealth companies that have entire SEO teams
• ROI: Eventually can be cost-effective, but requires sustained investment with no guarantees

Google Ads:

• Cost per click: $15-40+ for mental health and weight-loss keywords in competitive markets
• Conversion rate: Only 2-5% of clicks typically book appointments
• Cost per booked patient: Realistically $200-400+ when you factor in ad spend, landing page optimization, testing, and all the clicks that don’t convert
• Ongoing management: Either pay an agency 15-20% of ad spend or learn to manage campaigns yourself

Directory listings (Psychology Today, Zocdoc, etc.):

• Monthly subscription fees: $30-100+ per platform
• Additional per-booking fees on some platforms: $35-100+ per new patient (Zocdoc model)
• Competition: You’re one of hundreds of providers on the same page
• Total monthly cost: Can easily hit $500-1,000+ when paying for multiple listings

Reality check: A solo provider trying to build GLP-1 patient volume through DIY marketing might spend $3,000-5,000/month across these channels with highly variable results. Some months you get 10 new patients. Other months you get 2. You’re gambling on marketing effectiveness while paying the overhead regardless of outcome.

The Smarter Economic Model: Platform-Based Patient Acquisition

This is where platforms like Klarity Health change the economics entirely.

How it works:

• Zero upfront marketing spend — the platform handles all advertising and patient acquisition
• Pay per booked appointment — you only pay when a qualified patient actually books with you (similar to how Zocdoc works, but with better patient matching)
• Pre-qualified patients — these aren’t cold leads from generic ads; they’re patients who’ve already expressed interest in GLP-1 treatment, match your specialty and location, and have availability that fits your schedule
• Built-in infrastructure — telehealth platform, EHR integration, credentialing support, often even billing support

Why this makes sense economically:

Instead of spending $3,000-5,000/month on marketing with uncertain ROI, you pay a standard listing fee per new patient lead (typically in the range of what you’d pay for other per-patient acquisition models). The difference:

• Guaranteed ROI — you only pay when you see patients
• No wasted spend on ads that don’t convert
• No months of waiting for SEO to kick in
• Predictable economics — you know exactly what each new patient costs

Think of it this way: Would you rather spend $4,000/month on Google Ads that might generate 8-15 booked patients (if you’re lucky and skilled at PPC), or pay per patient as they book and eliminate all the risk?

The platform handles:

• National advertising and brand building
• Patient education and qualification
• Technology infrastructure (no separate EHR or telehealth platform costs)
• Insurance verification (if you accept insurance)
• Scheduling and calendar management
• Often credentialing and billing support

You control:

• Your schedule (set your own availability)
• Your rates (for cash-pay services)
• Your patient acceptance (you can decline patients who aren’t a fit)
• Your clinical approach

For most providers, especially those starting out or scaling quickly, this is the smart economic choice. You’re trading a relatively small per-patient fee for a complete patient acquisition and practice infrastructure that would cost exponentially more to build yourself.

Other Patient Sources Worth Considering

Internal referrals from your existing practice:This is the lowest-cost, highest-trust source. When you identify current psychiatric patients who meet GLP-1 criteria, you’re:

• Leveraging existing relationships (no acquisition cost)
• Serving patients who already trust you
• Addressing a real pain point they’ve likely mentioned
• Generating additional revenue from your current panel

Physician referrals and partnerships:Build relationships with:

• Primary care doctors who are overwhelmed with weight-loss requests
• Endocrinologists who focus on diabetes but not obesity management
• Bariatric surgeons who need pre-op or post-op weight management partners
• Therapists and dietitians who see patients struggling with weight and mental health

Send a brief email introducing your service: ‘I’m now offering medical weight management via telehealth for patients struggling with obesity, including those with psychiatric medications that cause weight gain. I’ll keep you updated and coordinate care. Here’s my referral process…’

Social media and content marketing:If you enjoy creating content, focus on education rather than hard selling:

• Share success stories (with permission)
• Explain how GLP-1s work
• Discuss the mental health aspects of weight loss
• Address common myths and fears

This builds authority and attracts patients organically over time, but don’t expect immediate results. Treat this as long-term brand building, not primary patient acquisition.

State-Specific Considerations

Let me give you the practical reality for the major markets:

California:

• Huge market, high obesity rates, tech-savvy patients comfortable with telehealth
• Medi-Cal (Medicaid) covers GLP-1s for obesity as of 2024, potentially increasing insurance-based demand
• NPs: Must work under physician supervision until 2026 when 104 NP independent status becomes available
• Telehealth: Requires patient consent (document this); no in-person requirement for non-controlled substances
• Not in IMLC — need full CA license to practice there

Texas:

• Very large market with high obesity prevalence and many underserved rural areas
• Strict NP supervision requirements — must have physician agreement
• IMLC member for physicians (easier multi-state licensing)
• Telehealth friendly: Can establish relationship via video, no in-person exam needed
• Most patients will be cash-pay (Texas Medicaid hasn’t expanded GLP-1 coverage widely)

Florida:

• Large, growing market with aging population seeking weight management
• Out-of-state physicians can use telehealth registration (easier access without full licensure)
• NPs must have physician collaboration (psychiatric NPs not eligible for independent practice)
• Telehealth: No in-person requirement; can prescribe GLP-1s remotely
• IMLC member for physicians

New York:

• Highly competitive in NYC, but upstate and rural areas underserved
• Experienced NPs (3,600+ hours) can practice independently — great for PMHNPs with experience
• Not in IMLC — need full NY license
• Strong telehealth parity laws encourage insurance coverage of telemed
• Significant patient population on antipsychotics/mood stabilizers (state facilities) who need weight management

Pennsylvania:

• Mix of urban and rural, with many provider shortage areas
• NPs must have collaborative agreement (no independent practice)
• IMLC member for physicians
• PA Medicaid began covering GLP-1s for obesity in 2024
• Recently joined nursing compact which may ease some cross-state practice

Illinois:

• Progressive NP policy: After 4,000 hours + education, NPs get full practice authority
• IMLC member for physicians
• Strong telehealth parity law
• IL Medicaid covers GLP-1s for obesity (one of few states)
• Good market for insurance-based model if you want that route

The Monitoring and Safety Piece You Can’t Skip

GLP-1s are generally safe, but you’re still prescribing powerful medications that affect metabolism, appetite, and potentially mood. Here’s what responsible monitoring looks like:

Baseline (before starting):

• Comprehensive history and physical (can be via telehealth video)
• BMI calculation and weight
• Labs: A1c, fasting glucose, comprehensive metabolic panel, TSH (lipid panel optional)
• Pregnancy test if applicable (GLP-1s contraindicated in pregnancy)
• Mental health screening
• Contraindication review (medullary thyroid cancer history, MEN2, pancreatitis history)

During treatment:

• Months 1-6: Monthly check-ins for dose titration, side effect monitoring, weight tracking
• Month 6+: Can space to every 2-3 months once stable on maintenance dose
• Repeat labs every 3-6 months (A1c, metabolic panel) to track metabolic improvements
• Always ask about mood, anxiety, suicidal thoughts — this is where your psych expertise shines. The FDA investigated potential suicide risk with GLP-1s in 2023-24 and found no clear causal link, but individual patients can experience mood changes. You’re equipped to catch and manage this.

Common side effects to monitor:

• GI: Nausea, vomiting, diarrhea, constipation (usually improves over time)
• Fatigue, dizziness (often related to calorie restriction, dehydration)
• Gallbladder issues (rare but monitor for RUQ pain)
• Hypoglycemia risk (if patient also on insulin or sulfonylureas)

Dose titration protocols:Follow standard escalation schedules (e.g., semaglutide 0.25mg weekly for 4 weeks, then 0.5mg, then 1mg, etc.). Don’t rush. Slower titration = fewer side effects = better adherence.

Document everything thoroughly:

• Informed consent about off-label use if applicable
• Weight and BMI at every visit
• Side effects discussed
• Lifestyle counseling provided
• Medication changes and rationale
• Follow-up plan

Good documentation protects you legally and clinically, plus helps track outcomes for quality improvement.

The Mental Health Integration Advantage

Here’s where you really differentiate from generic weight-loss clinics:

Screen for and address:

• Binge eating disorder — GLP-1s can reduce binge episodes, but addressing underlying triggers through therapy is crucial
• Emotional eating patterns — teach alternative coping strategies for stress, anxiety, boredom
• Body image issues — weight loss doesn’t automatically fix body dysmorphia or low self-esteem
• Depression/anxiety that sabotages lifestyle changes — maybe needs medication adjustment or therapy referral
• Motivation and readiness for change — use motivational interviewing techniques

Coordinate with existing psychiatric treatment:If a patient is already on psych meds that caused weight gain, you can:

• Discuss whether switching to weight-neutral alternatives makes sense (e.g., switching from olanzapine to aripiprazole if clinically appropriate)
• Monitor for any interactions or changes in psych med effectiveness as weight drops
• Adjust dosing of certain meds if weight loss affects pharmacokinetics

Provide realistic expectations:Weight loss is rarely linear. Patients plateau. Some regain. Set expectations upfront:

• ‘Most people lose 10-15% of body weight over 6-12 months, but individual results vary’
• ‘Plateaus are normal — we’ll work through them together’
• ‘This is a tool, not magic. Lifestyle changes matter’
• ‘Some people need to stay on medication long-term to maintain weight loss’

This kind of reality-based counseling prevents disappointment and dropout.

Building Retention and Community

Monthly support groups (virtual, 30-45 minutes):

• Led by you or a health coach
• Topics: Nutrition tips, exercise motivation, managing side effects, mindful eating
• Patients support each other, reducing isolation
• Builds loyalty to your practice

Educational content library:

• Video: ‘How to inject your medication’
• Handout: ‘Managing nausea on GLP-1s’
• Recipe ideas for high-protein, lower-calorie meals
• Exercise plans for beginners

Milestone recognition:Celebrate progress:

• 5% weight loss (clinically significant health improvement)
• 10% weight loss (major metabolic benefits)
• Maintaining weight loss for 6 months
• Non-scale victories (better energy, improved labs, medication reduction)

Clear policies around non-adherence:If patients miss appointments repeatedly, don’t take medications as prescribed, or don’t engage with lifestyle changes, have a conversation:

• ‘I’ve noticed you’ve missed the last three check-ins. Weight management requires regular monitoring for safety. Can we talk about barriers you’re facing?’
• Sometimes patients need a pause. Sometimes they’re not ready for change. It’s okay to step back and revisit when timing is better.

Avoiding Burnout: Non-Negotiable Self-Care

You can’t sustain a high-volume practice if you’re running on empty. Here’s what actually matters:

Schedule control:

• Block off admin time (no patients) for charting, renewals, emails
• Set maximum daily patient volume and stick to it
• Take real vacation (not ‘working remotely from the beach’)
• Use automated scheduling tools so you’re not playing calendar Tetris

Professional boundaries:

• Set communication hours (‘Messages answered 9am-5pm weekdays’)
• Use auto-responders for after-hours
• Train patients that urgent issues go to ER/crisis line, not your cell phone
• Say no to scope creep (you’re managing weight, not replacing their PCP for every issue)

Delegate and build a team:As revenue grows, reinvest in support:

• Medical assistant to handle intake, vitals, scheduling
• RN or health coach for lifestyle counseling and routine follow-ups
• Billing specialist if you accept insurance
• Virtual assistant for admin tasks

Monitor your own well-being:

• Check in monthly: Am I enjoying this work? Am I exhausted?
• Track metrics: If you’re seeing 30 patients/week and feeling fine, but 40/week wrecks you, that’s your ceiling — respect it
• Join provider communities for support and troubleshooting (obesity medicine forums, telehealth groups)
• Pursue training/CME that interests you — keeps the work engaging

The business angle:Burnout kills practices. It’s better to see 20 patients/week sustainably for years than to see 50/week, burn out in 6 months, and quit. Slow and steady wins.

The Bottom Line

Adding GLP-1 weight management to your psychiatric practice is one of the highest-ROI moves you can make right now — if you do it thoughtfully.

The demand is real. The clinical fit is strong. The revenue potential is significant. But none of that matters if you build a practice that exhausts you or compromises patient care.

Start small. Build efficient systems. Leverage technology and delegation. Choose patient acquisition strategies that give you predictable economics without gambling on expensive marketing. Protect your time and energy.

Most importantly, remember why this opportunity exists: millions of patients need effective weight management combined with mental health expertise. You can provide that better than generic weight-loss clinics because you understand the whole person — their biology, psychology, and behavioral patterns.

That’s not just good medicine. It’s a sustainable competitive advantage that will serve your practice for years to come.

Ready to add GLP-1 care to your practice without the patient acquisition headaches? Platforms like Klarity Health handle the marketing, technology, and patient matching so you can focus on clinical care. Join a network designed for psychiatric providers expanding into high-demand specialties — with predictable economics and built-in support.

Frequently Asked Questions

Q: Do I need special certification in obesity medicine to prescribe GLP-1s?

A: No. Any licensed physician or qualified APRN can prescribe GLP-1 medications within their scope of practice. Board certification in obesity medicine is optional but can boost credibility. Many psychiatrists start with basic CME on GLP-1 prescribing and obesity management, which is widely available online.

Q: What if I’m an NP in a state that requires physician collaboration?

A: You’ll need a supervising physician to sign off on your prescribing protocols. Many telehealth platforms provide supervising physicians as part of their infrastructure. Alternatively, you can establish an independent collaborative agreement with a local MD/DO who’s willing to oversee this service line. Make sure your agreement explicitly covers GLP-1 prescribing for weight management.

Q: Can I prescribe GLP-1s to patients in states where I’m not licensed?

A: No. You must hold an active license in the state where the patient is physically located at the time of the telehealth visit. Some states (like Florida for physicians) offer special telehealth registration for out-of-state providers, but you still need authorization to practice in that state. Interstate compacts (IMLC for physicians, some nursing compacts for NPs) can streamline multi-state licensing.

Q: How do I handle the cost issue when patients can’t afford brand-name medications?

A: Be transparent upfront. Discuss options: insurance coverage (if they have it), manufacturer savings cards (often available for Wegovy/Saxenda), or compounded semaglutide from reputable pharmacies ($200-400/month typically). Some patients will need to budget for this like any other chronic medication. If cost is prohibitive, discuss whether lifestyle-only intervention or waiting until they can afford medication makes sense. Don’t pressure patients into unaffordable treatment.

Q: What’s my liability exposure prescribing weight-loss drugs via telehealth?

A: As long as you follow standard of care — appropriate evaluation, informed consent, monitoring, documentation — your liability is no different than prescribing any other medication. Make sure your malpractice insurance covers telehealth and obesity/weight management services (most policies do, but confirm). Prescribing within your scope, documenting thoroughly, and following evidence-based protocols protects you legally.

Q: How do I know if a patient is appropriate for GLP-1 therapy?

A: FDA-approved criteria for obesity: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (diabetes, hypertension, sleep apnea, high cholesterol). Contraindications: personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis (relative contraindication), pregnancy/breastfeeding. Also assess motivation, mental health stability, and ability to commit to lifestyle changes. Patients looking for a quick fix without behavior change are less likely to succeed long-term.

Q: What if a patient experiences significant mood changes on GLP-1s?

A: This is where your psychiatric expertise is invaluable. While the FDA found no clear causal link between GLP-1s and suicidality, individual patients can experience mood shifts. Monitor closely, especially if they have pre-existing depression or anxiety. If mood deteriorates, consider dose reduction or medication discontinuation, coordinate with their mental health providers, and ensure appropriate psychiatric support. Document all discussions and clinical decisions.

Q: Can I scale this practice while still seeing psychiatric patients?

A: Absolutely. Many psychiatrists maintain a mixed practice — some days focused on mental health, some on weight management, or integrated appointments for patients receiving both. Start by dedicating specific time blocks to GLP-1 care (e.g., Friday afternoons) and gradually expand as you refine workflows. Some providers eventually transition fully to obesity medicine; others prefer variety. It’s your practice — design it around your strengths and interests.

Citations

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage). Published May 27, 2025. Available at: https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry.’ Published October 20, 2025. Available at: https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/

3. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny.’ Published August 22, 2025. Available at: https://time.com/7311517/cost-weight-loss-drugs-skinny/

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is